KEGG   PATHWAY: bta05332Help
Entry
bta05332                    Pathway                                

Name
Graft-versus-host disease - Bos taurus (cow)
Description
Graft-versus-host disease (GVHD) is a lethal complication of allogeneic hematopoietic stem cell transplantation (HSCT) where immunocompetent donor T cells attack the genetically disparate host cells. GVHD pathophysiology can be summerized in a three-step process. Step 1 involves the development of an inflammatory milieu resulting from damage in the host tissues induced by the preparative chemotherapy or radiotherapy regimen. Damaged tissues secrete inflammatory cytokines, including interleukin 1 (IL-1), and tumor necrosis factor (TNF-alpha ). During step 2, antigen-presenting cells (APCs) trigger the activation of donor-derived T cells, which induce further T-cell expansion, induce cytotoxic T lymphocytes (CTL) and natural killer (NK) cells responses and prime additional mononuclear phagocytes to produce TNF-alpha and IL-1. Also, nitric oxide (NO) is produced by activated macrophages, and it may contribute to the tissue damage seen during step 3. During step 3, the effector phase, activated CTL and NK cells mediate cytotoxicity against target host cells through Fas-Fas ligand interactions and perforin-granzyme B.
Class
Human Diseases; Immune diseases
BRITE hierarchy
Pathway map
Graft-versus-host disease
bta05332

All organismsOrtholog table
Organism
Bos taurus (cow) [GN:bta]
Gene
280826  
IL6; interleukin 6 (interferon, beta 2) [KO:K05405]
281250  
IL1A; interleukin 1, alpha [KO:K04383]
281251  
IL1B; interleukin 1, beta [KO:K04519]
280943  
TNF; tumor necrosis factor [KO:K03156]
282490  
BOLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]
282491  
BOLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]
282493  
BOLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]
282494  
BOLA-DQA5; major histocompatibility complex, class II, DQ alpha 5 [KO:K06752]
282495  
BOLA-DQB; major histocompatibility complex, class II, DQ beta [KO:K06752]
282498  
BOLA-DYB; major histocompatibility complex, class II, DY beta [KO:K06752]
282534  
BOLA-DQA1; major histocompatibility complex, class II, DQ alpha, type 1 [KO:K06752]
282535  
BOLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]
282530  
BOLA-DRB3; major histocompatibility complex, class II, DRB3 [KO:K06752]
525727  
BOLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]
506214  
BOLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]
539241  
BLA-DQB; MHC class II antigen [KO:K06752]
790858  
LA-DQB; MHC cell surface glycoprotein [KO:K06752]
SLA class II histocompatibility antigen; K06752 major histocompatibility complex, class II [KO:K06752]
uncharacterized LOC100296598; K10784 T cell receptor alpha chain V region [KO:K10784]
785283  
uncharacterized LOC785283; K10784 T cell receptor alpha chain V region [KO:K10784]
509513  
uncharacterized LOC509513; K10785 T-cell receptor beta chain V region [KO:K10785]
T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO:K10785]
T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO:K10785]
T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO:K10785]
T-cell receptor beta chain T17T-22-like; K10785 T-cell receptor beta chain V region [KO:K10785]
uncharacterized LOC100336183; K10785 T-cell receptor beta chain V region [KO:K10785]
510649  
immunoglobulin iota chain-like; K10785 T-cell receptor beta chain V region [KO:K10785]
407131  
CD80; CD80 molecule [KO:K05412]
414345  
CD86; CD86 molecule [KO:K05413]
281050  
CD28; CD28 molecule [KO:K06470]
280822  
IL2; interleukin 2 [KO:K05429]
407173  
JSP.1; MHC Class I JSP.1 [KO:K06751]
512672  
major histocompatibility complex; K06751 major histocompatibility complex, class I [KO:K06751]
BOLA-N; MHC class I antigen [KO:K06751]
515712  
BOLA; MHC class I heavy chain [KO:K06751]
782684  
BOLA-A; major histocompatibility complex, class I, A [KO:K06751]
507917  
BOLA; MHC class I heavy chain [KO:K06751]
509006  
class I histocompatibility antigen; K06751 major histocompatibility complex, class I [KO:K06751]
767904  
uncharacterized protein MGC126945; K06751 major histocompatibility complex, class I [KO:K06751]
407111  
FASLG; Fas ligand (TNF superfamily, member 6) [KO:K04389]
tumor necrosis factor ligand superfamily member 6-like; K04389 tumor necrosis factor ligand superfamily member 6 [KO:K04389]
282488  
FAS; Fas (TNF receptor superfamily, member 6) [KO:K04390]
369025  
PRF1; perforin 1 (pore forming protein) [KO:K07818]
508646  
GZMB; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) [KO:K01353] [EC:3.4.21.79]
281731  
GZMB; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) [KO:K01353] [EC:3.4.21.79]
281237  
IFNG; interferon, gamma [KO:K04687]
Compound
C00338  
Lipopolysaccharide
C00533  
Nitric oxide
Reference
  Authors
Ferrara JL, Reddy P.
  Title
Pathophysiology of graft-versus-host disease.
  Journal
Semin Hematol 43:3-10 (2006)
Reference
  Authors
Reddy P.
  Title
Pathophysiology of acute graft-versus-host disease.
  Journal
Hematol Oncol 21:149-61 (2003)
Reference
  Authors
Sun Y, Tawara I, Toubai T, Reddy P.
  Title
Pathophysiology of acute graft-versus-host disease: recent advances.
  Journal
Transl Res 150:197-214 (2007)
Reference
  Authors
Jaksch M, Mattsson J.
  Title
The pathophysiology of acute graft-versus-host disease.
  Journal
Scand J Immunol 61:398-409 (2005)
Reference
  Authors
Vogelsang GB, Lee L, Bensen-Kennedy DM.
  Title
Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.
  Journal
Annu Rev Med 54:29-52 (2003)
Reference
  Authors
Reddy P, Ferrara JL.
  Title
Immunobiology of acute graft-versus-host disease.
  Journal
Blood Rev 17:187-94 (2003)
Reference
  Authors
Blazar BR, Murphy WJ.
  Title
Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).
  Journal
Philos Trans R Soc Lond B Biol Sci 360:1747-67 (2005)
Reference
  Authors
Couriel D, Caldera H, Champlin R, Komanduri K.
  Title
Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.
  Journal
Cancer 101:1936-46 (2004)
Reference
  Authors
Jacobsohn DA, Vogelsang GB.
  Title
Acute graft versus host disease.
  Journal
Orphanet J Rare Dis 2:35 (2007)
KO pathway
 

DBGET integrated database retrieval system